Novartis AG
THERAPEUTIC REGIMEN
Last updated:
Abstract:
The present invention relates to dosing regimen of a new antimalarial drug, as monotherapy or combination therapy.
Status:
Application
Type:
Utility
Filling date:
30 Oct 2019
Issue date:
4 Jun 2020